Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Statement

8 Feb 2018 07:00

RNS Number : 2486E
Elektron Technology PLC
08 February 2018
 

Elektron Technology plc

(AIM: EKT, "Elektron" or the "Group")

Trading update

Elektron Technology plc, the global technology group, is pleased to provide an update on trading for the financial year ended 31 January 2018.

Group Trading

Group revenue from continuing operations for the full year is expected to be approximately £30.5m (unaudited) a 10.9% increase compared with £27.5m (on a like for like basis) for the previous year, returning the business to growth. Trading in the second half of the year from continuing operations, was substantially stronger than the first half as a result of the conversion of Bulgin's strong H1 order book to sales revenue. Revenue from continuing operations in the second half was £16.6m (unaudited) compared with £13.9m (unaudited) in the first half. Underlying trading performance from continuing operations benefitted from the operational gearing effect of increased sales over the prior year, improved Bulgin margins and efficiency improvements.

Sales

Sales from continuing operations* £m

Unaudited

FY 2018

FY 2017

% change

Bulgin

27.3

24.1

+13.3%

IMC (Queensgate and Elektron Eye Technology)

2.7

3.1

-12.9%

Checkit

0.5

0.3

+66.7%

Total Sales

30.5

27.5

+10.9%

* Excludes businesses disposed of during the year

Orders

Orders received in the year* £m

Unaudited

FY 2018

FY 2017

% change

Bulgin

29.3

25.7

+14.0%

IMC (Queensgate and Elektron Eye Technology)

3.8

2.4

+58.3%

Total Orders

33.1

28.1

+17.8%

*Checkit is excluded from the above table owing to its recurring revenue, subscription based model. Contracted recurring revenue (comprising already installed systems and those scheduled to be installed) as at 31 January 2018 was >£750k per annum (2017: £270k), an increase of 178%.

Bulgin

Bulgin ended the period with both sales and orders significantly ahead of the prior year. This was driven by the record level of sales made in the third quarter, however sales in the last quarter of the year returned to normalised levels. During the year Bulgin successfully launched its new "M-series" connector generating in excess of £500k of sales. Bulgin's fibre optic connector ranges are set for launch during the first half of this year.

IMC (Queensgate and Elektron Eye Technology ("EET"))

The sales decline in IMC was primarily due to destocking in EET in the early part of the year. Following a review of EET's commercial strategy, progress has been made in developing the EET global distribution channel. This is reflected in the full year order position which is significantly ahead of the prior year. During the year and as previously announced, EET acquired all IP relating to its product suite. EET also received notification from the US Food and Drug Administration (FDA) that the Henson 9000 is not subject to premarket registration under its clearance procedures thus paving the way for establishing a distribution network in the US.

Owing to the long term and unpredictable nature of the projects in which Queensgate operates, it was only able to deliver a modest increase in revenues. It does however start the new financial year with a significantly higher order book than a year ago.

Medical Service, a legacy element of the Agar Medical business which was closed in 2016 and was involved in servicing of medical devices, has now closed as planned. It was a marginal revenue and brand contributor to the Group and its revenues are no longer to be treated as part of continuing operations.

Checkit

Checkit continues to make progress with its real time operations management product suite. In particular, the adoption of Checkit has begun in two of the world's largest facilities management companies that employ over 1 million people between them. In addition, discussions are underway with several national and multi-national food service chains.

Cash

Group net cash was approximately £5.1m at 31 January 2018 (31 January 2017: £1.0m,) driven by a strong trading performance and the receipt of £1.9m cash proceeds from the Group's disposal process (namely Sheen Instruments, Digitron and Titman Tip Tools).

Outlook

The new financial year commenced with an order book in excess of £9m (unaudited) compared with £5.9m (unaudited) in the prior year.

The disposal programme has enabled management to focus solely on the businesses which the Board believes offer greatest potential for growth and realisation of significant shareholder value.

The Group plans to maintain its stated focus on new product development and expects to further invest during FY19 in order to continue to grow and maintain the momentum in the established and fledgling growth businesses.

John Wilson, Chief Executive Officer of Elektron, said:

"The business has delivered on its stated objective of returning the business to growth and starts the year with a strong order book. The Group is well positioned to continue to capitalise on the many opportunities available."

For further enquiries:

 

 

Elektron Technology plc

+44 (0) 1223 371 000 

www.elektron-technology.com

John Wilson (Chief Executive Officer)

Andrew Weatherstone (Chief Financial Officer & Company Secretary)

 

 

 

N+1 Singer (Nominated Adviser & Broker)

Shaun Dobson / Jen Boorer (Corporate Finance)

 +44 (0) 20 7496 3000 

Michael Taylor (Corporate Broking)

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

Notes to Editors:

Elektron conceives, designs and markets innovative products and services for business that connect, monitor and control. We have a multi skilled team of engineers, software and product line specialists based in Cambridge focused on the opportunities created by global growth in the following areas:

- Demand for ubiquitous power and data: Bulgin

- Real-time operations management using Internet of Things (IoT) technology: Checkit

- Screening for the effects of ageing on sight: Elektron Eye Technology

- High precision nano-scale manufacture: Queensgate

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBCGDDLGGBGIR
Date   Source Headline
1st Feb 20137:00 amRNSTrading update
28th Jan 20137:00 amRNSHolding(s) in Company
10th Jan 20134:51 pmRNSHolding(s) in Company
2nd Jan 20132:54 pmRNSCompletion of disposal
3rd Dec 20127:00 amRNSProduct Launch
28th Nov 20127:00 amRNSDirector/PDMR Shareholding
27th Nov 20127:00 amRNSDisposal
1st Oct 20123:16 pmRNSDirector/PDMR Shareholding
13th Sep 20121:26 pmRNSDirector/PDMR Shareholding
13th Sep 20127:00 amRNSHalf year results
3rd Sep 20127:00 amRNSProduct Launch
31st Aug 20129:10 amRNSNotice of Results
23rd Aug 20124:37 pmRNSHolding in Company
21st Aug 20124:09 pmRNSDirector/PDMR Shareholding
20th Aug 201211:35 amRNSCorrection: Issue of scrip dividend shares
13th Aug 20128:04 amRNSIssue of Equity
31st Jul 20127:00 amRNSLaunch of new range of waterproof connectors
25th Jul 20124:16 pmRNSHolding(s) in Company
17th Jul 20121:15 pmRNSHolding(s) in Company
10th Jul 20121:50 pmRNSHolding(s) in Company
6th Jul 201211:47 amRNSHolding(s) in Company
3rd Jul 20127:00 amRNSBoard Changes
28th Jun 20125:36 pmRNSResolutions Passed
28th Jun 201210:19 amRNSDirector Dealing
28th Jun 20127:00 amRNSAGM Statement
7th Jun 201210:33 amRNSHolding(s) in Company
17th May 20127:00 amRNSAnnual Report and Notice of AGM
12th Apr 20127:00 amRNSFull year results
30th Mar 201211:04 amRNSNotice of Results
21st Feb 201210:27 amRNSHolding(s) in Company
1st Feb 20127:00 amRNSTrading update
18th Jan 20127:00 amRNSDirector/PDMR Shareholding
29th Dec 201112:57 pmRNSDirector/PDMR Shareholding
20th Dec 20117:00 amRNSDirector/PDMR Shareholding
9th Dec 20118:13 amRNSDirector/PDMR Shareholding
5th Dec 20117:00 amRNSDirector/PDMR Shareholding
30th Nov 20117:00 amRNSIssue of Equity
23rd Nov 201112:13 pmRNSHolding(s) in Company
22nd Nov 20111:14 pmRNSDirector/PDMR Shareholding
17th Nov 20117:00 amRNSTrading update
16th Nov 20111:24 pmRNSHolding(s) in Company
9th Nov 20117:00 amRNSHolding(s) in Company
4th Oct 20114:28 pmRNSDoc re. interim report and scrip dividend circular
20th Sep 20117:00 amRNSHolding(s) in Company
15th Sep 20117:00 amRNSHalf Yearly Report
24th Aug 201111:58 amRNSHolding(s) in Company
23rd Aug 20114:53 pmRNSDirector/PDMR Shareholding
23rd Aug 20114:46 pmRNSHolding(s) in Company
12th Aug 20117:00 amRNSIssue of Scrip Dividend Shares
29th Jul 20113:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.